From the Editors

Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines More
Briefing
Care Management
Moving beyond the glucometer More
Briefing
Health Equity
New CVS Health Chief Health Equity Officer Outlines Her Vision for the Future More
Briefing
Cost Management
... More
Feature
Drug Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon More
Briefing
Drug Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline More
Briefing
Care Management
Health Advisor provides plan member support and helps lower costs to proactively connect with members to improve health outcomes. More
Video